Framing disease: The example of female hypoactive sexual desire disorder

Social Science and Medicine

Volumn 70, Issue 7, 2010, Pages 1084-1090

  Jutel, Annemarie ^a  

^a OTAGO POLYTECHNIC   (New Zealand)

Author keywords

Gender; Medicalisation; Pharmaceutical industry; Sexuality; Sociology of diagnosis

Indexed keywords

ANTIDEPRESSANT AGENT; FLIBANSERIN;

FEMALE BEHAVIOR; GENDER ISSUE; PATHOLOGY; PHARMACEUTICAL INDUSTRY; SEXUAL BEHAVIOR; SEXUALITY; WOMENS HEALTH;

ARTICLE; COMMERCIAL PHENOMENA; CONSENSUS DEVELOPMENT; DISEASE CLASSIFICATION; DRUG APPROVAL; FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER; FEMALE SEXUAL DYSFUNCTION; HUMAN; HYPERSEXUALITY; LIBIDO DISORDER; PATENT; SOCIAL ATTITUDE; CLASSIFICATION; DRUG INDUSTRY; FEMALE; GENERAL ASPECTS OF DISEASE; HISTORY; LIBIDO; PSYCHOSEXUAL DISORDER; SEXUALITY; SOCIOLOGY;

DISEASE; DRUG INDUSTRY; FEMALE; HISTORY, 20TH CENTURY; HUMANS; LIBIDO; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SEXUALITY; SOCIOLOGY, MEDICAL;

EID: 77951228101     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2009.11.040     Document Type: Article

References (68)

1. Abraham J. Sociology of pharmaceuticals development and regulation: a realist empirical research programme. Sociology of Health and Illness 2008, 30(6):869-885.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM III) 1980, APA, Washington, DC.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1987, APA, Washington, DC.
4. Aronowitz R. When do symptoms become a disease?. Annals of Internal Medicine 2001, 134(9 part 2):803-808.
5. Aronowitz R. Framing disease: an underappreciated mechanism for the social patterning of health. Social Science & Medicine 2008, 67(1):1-9.
6. Attwood F. Sexed up: theorizing the sexualization of culture. Sexualities 2006, 9(1):77-94.
7. Basson R., Berman J., Burnett A., Derogatis L., Ferguson D., Fourcroy J., et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. Journal of Urology 2000, 163(3):888-893.
8. Boehringer Ingelheim GmbH Hypoactive sexual desire disorder backgrounder 2008, Boehringer Ingelheim.
9. Bogaert A.F. Asexuality: prevalence and associated factors in a national probability sample. Journal of Sex Research 2004, 41(3):279-287.
10. Borsini F., Cesana R., Kelly J., Leonard B.E., McNamara M., Richards J., et al. BIMT 17: a putative antidepressant with a fast onset of action?. Psychopharmacology 1997, 134(4):378-386.
11. Borsini, F., & Evans, K. R. (2006). Method of treating female hypoactive sexual desire disorder with flibanserin. US Patent Office, US Patent 7151103(10/272603).
12. Borsini F., Giraldo E., Monferini E., Antonini G., Parenti M., Bietti G., et al. BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex. Naunyn-Schmiedebergs Archives of Pharmacology 1995, 352(3):276-282.
13. Bowker G.C., Star S.L. Sorting things out: Classification and its consequences 1999, MIT Press, Cambridge, MA.
14. Brady, A. (2007). Constituting queer: performativity and commodity culture. Media studies. PhD thesis, Dunedin: University of Otago.
15. Brown P. Naming and framing: the social construction of diagnosis and illness. Journal of Health and Social Behavior, Health Module 1995, 34-52.
16. Carey J. Viagra for women?. Business Week 28 December 2006, Retrieved 19 October 2009 from:. http://www.businessweek.com/bwdaily/dnflash/content/dec2006/db20061228_3 15249.htm.
17. Charland L.C. A madness for identity: psychiatric labels, consumer autonomy, and the perils of the internet. Philosophy, Psychiatry, & Psychology 2004, 11(4):336-349.
18. Conrad P. The shifting engines of medicalization. Journal of Health and Social Behavior 2005, 46(1):3-14.
19. Clayton A.H., Goldfischer E.R., Goldstein I., Derogatis L., Lewis-D'Agostino D.J., Pyke R. Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). Journal of Sexual Medicine 2009, 6(3):730-738.
20. Conrad P., Leiter V. From Lydia Pinkham to Queen Levitra: direct-to-consumer advertising and medicalisation. Sociology of Health and Illness 2008, 30(6):825-838.
21. Cushman P. Why the self is empty: toward a historically situated psychology. American Psychologist 1990, 45(5):599-611.
22. Derogatis L.R., Rosen R., Leiblum S., Burnett A., Heiman J. The female sexual distress scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. Journal of Sex and Marital Therapy 2002, 28(4):317-330.
23. Dumit J. Illnesses you have to fight to get: facts as forces in uncertain, emergent illnesses. Social Science & Medicine 2006, 62(3):577-590.
24. Fox N., Ward K., O'Rourke A. Pro-anorexia, weight-loss drugs and the internet: an " anti-recovery" explanatory model of anorexia. Sociology of Health and Illness 2005, 27(7):944-971.
25. Freidson E. Profession of medicine: A study of the sociology of applied knowledge 1972, Dodd, Mead & Company, New York.
26. Furedi F. The end of professional dominance. Society 2006, 43(6):14-18.
27. Hacking I. Inaugural lecture: chair of philosophy and history of scientific concepts at the collège de France, 16 January 2001. Economy and Society 2001, 31(1):1-14.
28. Hollick F.D. The origin of life and process of reproduction in plants and animals, with the anatomy and physiology of the human generative system, male and female, and the causes, prevention and cure of the special diseases to which it is liable, a plain, practical treatise, for popular use 1902, David McKay, Philadelphia.
29. Jagose A. Against love. A paper delivered to the department of cinema studies 2003, New York University, New York City, NY, 7 February.
30. Jutel A. The emergence of overweight as a disease category: measuring up normality. Social Science & Medicine 2006, 63(9):2268-2276.
31. Jutel A. Sociology of diagnosis: a preliminary review. Sociology of Health & Illness 2009.
32. Kaplan H.S. Hypoactive sexual desire. Journal of Sex and Marital Therapy 1977, 3(1):3-9.
33. Kilbourne J. Advertising and disconnection. Sex in advertising 2003, 173-180. Lawrence Erlbaum Associates, Mahwah, NJ. T. Reichert, J. Lambiase (Eds.).
34. Kuczmarski R.J., Flegal K.M. Criteria for definition of overweight in transition: background and recommendations for the United States. American Journal of Clinical Nutrition 2000, 72(5):1074-1081.
35. Laqueur T. Making sex: Body and gender from the Greeks to freud 1990, Harvard University Press, Cambridge, MA.
36. Lief H.I. Inhibited sexual desire. Medical Aspects of Human Sexuality 1977, 7:94-95.
37. Lunbeck E. " A new generation of women": progressive psychiatrists and the hypersexual female. Feminist Studies 1987, 13(3):513-543.
38. Martin E. Medical metaphors of women's bodies: menstruation and menopause. Writing on the body 1997, Columbia University Press, New York. K. Conboy, N. Medina, S. Stanbury (Eds.).
39. Melendy M.R. Vivilore: The pathway to mental and physical perfection 1904, Milton Porter, Wellington, NZ.
40. Meyer-Kleinmann J. Largest study of its kind reveals low sexual desire is most common female sexual problem. Boehringer Ingelheim Science and Technology Communications 2008.
41. Meyer-Kleinmann J. Women suffering from decreased sexual desire: silence hinders diagnosis of the prevalent condition hypoactive sexual desire disorder (HSDD). Boehringer Ingelheim Science and Technology Communications 2008.
42. Mirowsky J., Ross C.E. Psychiatric diagnosis as reified measurement. Journal of Health and Social Behavior 1989, 30(1):11-25.
43. Moncrieff J., Hopker S., Thomas P. Psychiatry and the pharmaceutical industry: who pays the piper?. Psychiatric Bulletin 2005, 29:84-85.
44. Moynihan R. The making of a disease: female sexual dysfunction. British Medical Journal 2003, 326(7379):45-47.
45. Moynihan R., Henry D. The fight against disease mongering: generating knowledge for action. PLoS Med 2006, 3(4):e191.
46. Napheys G.H. The physical life of woman: Advice to the maiden, wife and mother 1871, George Maclean, Philadelphia.
47. Ovid Metamorphoses, book III 1985, Aris & Phillips, Ltd, Warminster, UK.
48. Parry V. Disease branding: what is it, why it works and how to do it. Pharmaceutical Executive, October 2007, 22-24.
49. Payer L. Disease-mongers: How doctors, drug companies, and insurers are making you feel sick 1992, John Wiley & Sons, Inc, New York.
50. Prause N., Graham C.A. Asexuality: classification and characterization. Archives of Sexual Behavior 2007, 36(3):341-356.
51. Procter & Gamble Pharmaceuticals UK Ltd Intrinsa 300 micrograms/24 hours transdermal patch Retrieved 19 October 2009 from. http://intrinsa.co.uk/media/downloads/en/Intrinsa%20SPC%2016-09-2008.pdf .
52. Reichert T., Lambiase J. One phenomenon, multiple lenses: bridging perspectives to examine sex in advertising. Sex in advertising: Perspectives on the erotic appeal 2003, 1-10. Lawrence Erlbaum Associates, Mahwah, NJ. T. Reichert, J. Lambiase (Eds.).
53. Richardson D. Patterned fluidities: (re)imagining the relationship between gender and sexuality. Sociology 2007, 41(3):457-474.
54. Roberts M.L. Gender, consumption, and commodity culture. The American Historical Review 1998, 103(3):817-844.
55. Rosenberg C.E. The tyranny of diagnosis: specific entities and individual experience. The Milbank Quarterly 2002, 80(2):237-260.
56. Rothblum E.D., Brehony K.A. Boston marriages: Romantic but asexual relationships among contemporary lesbians 1993, University of Massachusetts Press, Amherst, MA.
57. Scherrer K.S. Coming to an asexual identity: negotiating identity, negotiating desire. Sexualities 2008, 11(5):621-641.
58. Shifren J.L., Monz B.U., Russo P.A., Segreti A., Johannes C.B. Sexual problems and distress in United States women: prevalence and correlates. Obstetrics and Gynecology 2008, 112(5):970-978.
59. Sills T., Wunderlich G., Pyke R., Segraves R.T., Leiblum S., Clayton A., et al. The sexual interest and desire inventory-female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder. Journal of Sexual Medicine 2005, 2(6):801-818.
60. St-Onge M., Provencher H., Ouellet C. Entendre des voix: nouvelles voies ouvrant sur la pratique et la recherche. Sante Mentale Au Quebec 2005, 30(1):125-150.
61. Stewart J.A. The young woman' s companion; or, female instructor: Being a sure and complete guide to every acquirement essential in forming a pleasing companion, a respectable mother, or a useful member of society 1814, Bartlett and Newman, Oxford.
62. Tiefer L. The medicalization of sexuality: conceptual, normative, and professional issues. Annual Review of Sex Research 1996, 7:252-282.
63. Tiefer L. Female sexual dysfunction: a case study of disease mongering and activist resistance. PLoS Medicine 2006, 3(4):e178.
64. Ware N.C. Suffering and the social construction of illness: the delegitimation of illness experience in chronic fatigue syndrome. Medical Anthropology Quarterly 1992, 6(4):347-361.
65. Wolinsky H. Disease mongering and drug marketing. European Molecular Biology Organization 2005, 6(7):612-614.
66. Woloshin S., Schwartz L. Giving legs to restless legs: a case study of how the media helps make people sick. PLoS Medicine 2006, 3(4):e170.
67. World Health Organisation International statistical classification of diseases and related health problems 9th revision 1977, WHO, Geneva.
68. World Health Organisation International statistical classification of diseases and related health problems 10th revision 1994, WHO, Geneva.